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Background. To explore the potential role of natural-resistance-associated macrophage protein 1 (NRAMP1) gene, vitamin D
receptor (VDR) gene, (human leukocyte antigen, (HLA-DRB1) HLA) -DRB1 gene, and HLA-DQB1 gene polymorphisms in
susceptibility to tuberculosis (TB) in the Chinese Kazakh population. Methods. A case-control study was performed on the
Chinese Kazak population. Genetic polymorphisms of NRAMP1 gene (3󸀠UTR) and VDR gene (TaqI and FokI) were analysed
using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and sequencing analysis in TB patients
and healthy controls. Genetic polymorphisms of HLA-DRB1 gene and HLA-DQB1 gene in the two groups were detected with
polymerase chain reaction-sequence-specific primers (PCR-SSPs) technique and sequencing analysis.Results.Therewas statistically
significant difference in the 3󸀠UTR polymorphism between the TB patients and healthy controls in the Chinese Kazak population
(𝑃 = 0.002; OR = 1.859; 95% CI = 1.182–2.926). Significant difference was observed in the FokI polymorphism between the TB
patients and healthy controls (𝑃 = 0.001; OR = 1.530; 95% CI = 1.007–2.325). It does not disclose any significant association
between the disease and TaqI (𝑃 > 0.05). Alleles HLA-DRB1∗04 and HLA-DQB1∗0201 occurred more frequently in patients than
in controls (𝑃 = 0.011 and 0.002; OR = 1.889 and 1.802; 95% CI = 1.153–3.095 and 1.230–2.639, resp.). Conclusions. Polymorphisms
in the NRAMP1 gene, VDR gene, HLA-DRB1 gene, and HLA-DQB1 gene are statistically associated with susceptibility to TB in the
Chinese Kazakh population.
1. Introduction
Tuberculosis (TB) remains a global health problem with 9.4
million new cases and 1.7 million deaths from TB a year. It is
estimated that 1/3 of the world’s population has been infected
withMycobacterium tuberculosis, and only a small proportion
(10%) of those infected will develop to clinical disease during
their life time. In addition, more than half of all TB cases
occurred in Asia in 2009, which is far higher than other areas
[1].
And ninety-five percent of TB cases and 98% of TB deaths
are in developing countries [2]. Meaningfully, the incidence
of TB is different in different countries, ethnic groups and
populations [3]. China ranks the second in the world in
the incidence of TB. Especially, the incidence of TB in the
Xinjiang Uygur Autonomous Region (Northwest China) is
higher than the average level of China. The TB epidemic
situation in minority is significantly higher than that of the
Han. For example, the prevalence rate of active, sputum
smear, and culture positive TB in minority of the Xinjiang
Uygur Autonomous Region was 12.4, 16.9, and 18.4 times that
of the Han, respectively [4].
Many lines of evidence support a significant role for host
genetic variation in susceptibility to TB [5, 6], and a complex
interaction of genetic and environmental factors cause the
development of clinical TB. A number of genes are thought
to be important in the pathogenesis of TB [7, 8].
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Table 1: TB cases and controls included in the analyses of NRAMP1,
VDR, and HLA as candidate genes in TB susceptibility.
NRAMP1 genotyping VDR genotyping HLA genotyping
3󸀠UTR FokI TaqI DRB1 DQB1
TB cases 213 213 231
Controls 211 211 230
There is substantial evidence from studies on racial
variation in susceptibility to TB [9, 10]. Polymorphisms
in some genes have been found to be associated with
TB in different ethnic groups. However, the results have
been inconclusive. The specific aim of this study was to
investigate the associations of NRAMP1 gene, VDR gene,
HLA-DRB1 gene, and HLA-DQB1 gene polymorphisms in
susceptibility to TB in the Chinese Kazak population. The
difference between frequencies of these gene polymorphisms
discovered susceptibility to TB and supplies the experimental
data for TB risk assessment in the Chinese Kazak population.
2. Methods
2.1. Cases andControls. KazakhChinese populationswithout
miscegenation were selected from Tacheng region in the
Xinjiang Uygur Autonomous Region of China, TB patients
from the Tacheng District Hospital. All subjects agreed to
take part in the study. Participants’ eligibility was confirmed
by questionnaire and clinical examinations after enrollment
in the study.The cases were selected according to the national
diagnostic criteria of China, with positive sputum smear or
culture, or significant symptoms of typical PTB, chest radiog-
raphy consistent with active disease, and a positive tuberculin
skin test in case of negative sputum smear or culture. A
control group composed of ethnically matched, unrelated
individuals were also included in the analyses. None of the
controls showed any clinical manifestations of PTB at the
time of blood sample collection, and all were confirmed
to be free from PTB by X-ray examination. Subjects, who
were HIV positive and known to present any autoimmune,
chronic inflammatory, or any other disease conditions, were
excluded from the study. All selected participants had no
mixed descendants within three generations. The study was
approved by the Ethics Committee of the Faculty ofMedicine
(Huazhong University of Science and Technology, China),
and informed consents were obtained from all subjects before
blood sampling. Venous blood (3.0mL) with anticoagulant
was preserved in −80∘C freezer for DNA extraction and
detection of gene polymorphism. Table 1 shows how many
of the samples from recruited cases and controls could
be utilized in the NRAMP1, VDR, and HLA genotyping
experiments, respectively.
The patients aged from 18 to 72 years. We used the
comparison design and analysis.The result shows that there is
no age and sex statistical difference between TB patients and
healthy controls.
2.2. Genotyping of NRAMP1 and VDR Gene. Genomic DNA
was extracted using the phenol-chloroform method [11].
The present study was carried out to determine the distri-
bution of gene polymorphisms using a PCR-based restriction
analysis. For the NRAMP1 gene, 3󸀠UTR polymorphism site
was investigated. For the VDR gene, TaqI and FokI polymor-
phism sites were detected.
Polymerase chain reaction (PCR) and restriction frag-
ment length polymorphism (RFLP) analysiswere used to type
polymorphisms of NRAMP1 and VDR genes. The primers
used for amplification of NRAMP1 and VDR gene polymor-
phisms were designed using the prime 5.0 (Table 2). PCR
amplifications were performed using purified DNA in 25𝜇L
reaction volumes.Thermocycling parameters were as follows:
95∘C for 5min and 35 cycles of 95∘C for 30 s, 58∘C for 45 s,
and 72∘C for 45 s, with a final extension at 72∘C for 10min.
PCR products were then digested using 1.0𝜇L (10U/𝜇L) of
restriction endonuclease per reaction under the conditions
recommended by the manufacturer (Takara, Kyoto, Japan).
Digestion productswere separated by electrophoresis on 2.5%
agarose gel, stained with ethidium bromide, and visualised
under ultraviolet light.The genotypes were defined according
to generated fragment patterns.The restriction endonuclease
used in each polymorphism and the defined genotypes are
listed in Table 2. 10% PCR products were verified by DNA
sequencing (Shanghai GeneCore Bio Technologies Co. Ltd.).
2.3. Genotyping of HLA-DRB1 and HLA-DQB1. All samples
were typed for HLA-DRB1 and HLA-DQB1 using PCR-SSP,
The primer sequence and product size are listed in Table 3.
A conserved sequence of human growth hormone (HGH)
was amplified in each reaction as an internal control primer;
former and reverse primer sequences are 5-GCCTTCCCAA-
CCATTCCCTTA-3 and 5-TCACGGATTTCTGTTGTGT-
TTC-3. PCR amplifications were performed in 25𝜇L reaction
volumes containing 100 ng genomic DNA, 50mM Tris-HCl,
2.5mM MgCl
2
, 20mM each deoxynucleotide triphosphate,
10 pmol each primer, and 1U of Taq DNA polymerase.
Thermocycling parameters were as follows: denaturation at
94∘C for 5min and 30 cycles of 94∘C for 30 s, 60∘C for 45 s,
and 72∘C for 45 s, with a final extension at 72∘C for 5min.
Amplified products were resolved using agarose (Roche,
Mannheim, Germany) gel electrophoresis. The genotypes
were defined according to generated fragment patterns. 10%
PCR products were verified by DNA sequencing (Shanghai
GeneCore Bio Technologies Co., Ltd.).
2.4. Quality Control. All tests of genetic polymorphismswere
processed by sophisticated laboratory personnel.The samples
were reexamined if results were inconsistent.
2.5. Data and Statistical Analysis. Data were managed and
analysed using SPSS (version 13.0). For each polymorphism,
allele and genotype frequency differences in each group were
examined by the chi-squared test or Fisher’s exact test when
appropriate. Odds ratios (ORs) and 95% confidence intervals
(CIs) were calculated to quantitatively assess the degree of
association between these polymorphisms and tuberculosis.
Hardy-Weinberg equilibrium (HWE) was tested for each
SNP. Differences were considered statistical significance at
𝑃 < 0.05.
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Table 2: NRAMP1 and VDR polymorphism sites and sequence variants.
Name Nucleotide and aminoacid change Primers, 5
󸀠 to 3󸀠 Polymorphic site Genopytes Fragment(bp)
NRAMP1-
3󸀠UTR
Deletion of TGTG in the
3󸀠UTR (55 nt 3󸀠 to the
last codon in exon 15)
GCATCTCCCCAATTCATGGT TGTGdel/del 240
AACTGTCCCACTCTATCCTG TGGATGTGGA TGTG+/del 240, 211, 33
(240 or 242 bp) FokI TGTG+/+ 211, 33
VDR-FokI A T/C transitionpolymorphism in exon 2
AGCTGGCCCTGGCACTGACTCTGCTCT C/C-FF 267
ATGGAAACACCTTGCTTCTTCTCCCTC CAGGGATGGAGG T/C-Ff 267, 197, 70
(267 bp) FokI T/T-ff 197, 70
VDR-TaqI
A single base change CAGAGCATGGACAGGGAGC T/T-TT 455
C to T in codon 352 at
the 3󸀠 end of the AGGAGAGGCAGCGGTACTG ACAGGAGCTCT T/C-Tt
455, 290,
165
VDR gene (455 bp) TaqI C/C-tt 290, 165
Note: Underlined letters denote different restriction sites in which bold letters represent polymorphism sites. Genotypes of both genes were defined as follows.
For the NRAMP1 gene, individuals were scored as 3󸀠UTR-TGTG+/+ wild homozygote, 3󸀠UTR-TGTGdel/del mutant homozygote, and 3󸀠UTRTGTG+/del
heterozygote, respectively.
+= presence of TGTG; del = absence of these four bases.
For the VDR gene, individuals were scored as FokI-FF, TaqI-TT wild homozygotes, FokI-ff, TaqI-tt mutant homozygotes, FokI-Ff, and TaqI-Tt heterozygotes,
respectively.
Table 3: The primers and product size for PCR-SSP genotyping of HLA-DRB1 and HLA-DQB1.
Primer sequence (5󸀠 to 3󸀠) Size of PCR products (bp)
For Rev
DRB1 allele
01 TTGTGGCAGCTTAAGTTTGAAT CTGCACTGTGAAGCTCTCAC 255
03 TACTTCCATAACCAGGAGGAGA TGCAGTAGTTGTCCACCCG 151
04 GTTTCTTGGAGCAGGTTAAACA󸀠 CTGCACTGTGAAGCTCTCAC 260
07 CCTGTGGCAGGGTAAGTATA CCCGTAGTTGTGTCTGCACAC 232
08 AGTACTCTACGGGTGAGTGTT󸀠 CTGCAGTAGGTGTCCACCAG 214
09 GTTTCTTGAAGCAGGATAAGTTT CCCGTAGTTGTGTCTGCACAC 236
10 CGGTTGCTGGAAAGACGCC CTGCACTGTGAAGCTCTCAC 204
11 GTTTCTTGGAGTACTCTACGTC CTGGCTGTTCCAGTACTCCT 176
12 AGTACTCTACGGGTGAGTGTT CACTGTGAAGCTCTCCACAG 248
13 ACTTCCATAACCAGGAGGAGA CCCGCTCGTCTTCCAGGAT 130
14 GTTTCTTGGAGTACTCTACGTC TCTGCAATAGGTGTCCACCT 224
15 TCCTGTGGCAGCCTAAGAG CCGCGCCTGCTCCAGGAT 197
16 TCCTGTGGCAGCCTAAGAG AGGTGTCCACCGCGGCG 223
DQB1 allele
0201 GTGCGTCTTGTGAGCAGAAG GCAAGGTCGTGCGGAGCT 205
0301/4 GACGGAGCGCGTGCGTTA AGTACTCGGCGTCAGGCG 122
0302/3 GACGGAGCGCGTGCGTCT󸀠 AGTACTCGGCGTCAGGCG 122
0303 GACGGAGCGCGTGCGTCT CTGTTCCAGTACTCGGCGT󸀠 129
0304 GACGGAGCGCGTGCGTTA CTGTTCCAGTACTCGGCGG 129
0401 CACCAACGGGACCGAGCT GGTAGTTGTGTCTGCATACG 200
0402 CACCAACGGGACCGAGCG GGTAGTTGTGTCTGCATACG 200
0501 CGGAGCGCGTGCGGG GCTGTTCCAGTACTCGGCAA 128
0502 TGCGGGGTGTGACCAGAC TGTTCCAGTACTCGGCGCT 117
0503 TGCGGGGTGTGACCAGAC GCGGCGTCACCGCCCGA 87
0504 GTGCGGGGTCTGACCAGAT TGTTCCAGTACTCGGCGCT 118
0601 GCCATGTGCTACTTCACCAAT CACCGTGTCCAACTCCGCT 198
0602 CGTGCGTCTTGTGACCAGAT GCTGTTCCAGTACTCGGCAT 121
0603/8 GGAGCGAGTGCGTCTTGTA GCTGTTCCAGTACTCGGCAT 127
0604 CGTGTACCAGTTTAAGGGCA GCAGGATCCCGCGGTACC 254
Note: For: former; Rev: reverse.
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Table 4: Genotype and allele frequency distribution of NRAMP1 and VDR genes in the controls and TB patients of the Chinese Kazak
population.




2 OR (95% CI) 𝑃
NRAMP1-3󸀠UTR
TGTG++ 138 (64.8) 167 (79.1) 1.00
TGTG+/del 63 (29.6) 41 (19.5) 12.802 1.859 (1.182–2.926) 0.002
TGTGdel/del 12 (5.6) 3 (1.4) 4.841 (1.339–17.499)
Alleles
TGTG 339 (79.6) 375 (88.9) 13.737 2.048 (1.395–3.006) <0.001
TGTGdel 87 (20.4) 47 (11.1)
VDR-FokI
FF 72 (33.8) 101 (47.9) 1.00
Ff 96 (45.1) 88 (41.7) 13.095 1.530 (1.007–2.325) 0.001
ff 45 (21.1) 22 (10.4) 2.869 (1.586–5.191)
Alleles
F 240 (56.3) 290 (68.7) 13.868 1.703 (1.285–2.255) <0.001
f 186 (43.7) 132 (31.3)
VDR-TaqI
TT 191 (89.7) 183 (86.7) 1.00
Tt 19 (8.9) 23 (10.9) — 0.791 (0.417–1.502) 0.581
tt 3 (1.4) 5 (2.4) 0.575 (0.135–2.440)
Alleles
T 401 (94.1) 389 (92.2) 1.267 0.735 (0.429–1.259) 0.260
t 25 (5.9) 33 (7.8)
Note: Genotype frequencies were compared between the patients and control subjects by 𝜒2 test or Fisher’s exact test when appropriate. Allele frequencies
were compared between the patients and control subjects by use of a 𝜒2 test for 2-by-2 contingency tables. 𝑁: the sample size; OR: odds ratio; 95% CI: 95%
confidence interval; Freq: frequency.
3. Results
3.1. Distribution of the Selected NRAMP1 and VDR Gene
Polymorphisms. The distribution of NRAMP1 and VDR
polymorphisms in 424 Chinese Kazakhs did not deviate from
the Hardy-Weinberg equilibrium (𝑃 > 0.05). The frequencies
of 3󸀠UTR, FokI, andTaqI SNP in patientswithTBwere 35.2%,
66.2%, and 10.3%, respectively, whereas the frequencies in
healthy controls were 20.9%, 52.1%, and 13.3%, respectively
(Table 4).
The TGTGdel, f, and t allele frequencies of 3󸀠UTR, FokI,
and TaqI SNP in patients with TB were 20.4%, 43.7%, and
5.9%, respectively, whereas the allele frequencies in healthy
controls were 11.1%, 31.3%, and 7.8%, respectively (Table 4).
The data showed that in Kazak population, the TGTGdel
and f allele frequencies of the 3󸀠UTR and the FokI SNPs in
the patient groups were higher than in the control groups,
indicating significant differences between the two groups
(𝑃 = 0.000 and 0.000, resp.). No significant difference in the
t allele frequency was observed between the TB patients and
the controls (𝑃 = 0.260) (Table 4).
Our results showed that the polymorphisms of the
NRAMP1 gene (3󸀠UTR) and VDR gene (FokI) are signifi-
cantly associated with TB and may be risk factors for the
development of TB in the Chinese Kazak population (OR =
1.859 and 1.530; 𝑃 = 0.002 and 0.001, resp.). Our results
indicated that the polymorphism in the TaqI of the VDR gene
is not associated with TB (𝑃 = 0.581).
3.2. Distribution of the Selected HLA-DRB1 and HLA-DQB1
Gene Polymorphisms. The distribution of HLA-DRB1 and
HLA-DQB1 polymorphisms in 461 Chinese Kazakhs did not
deviate from the Hardy-Weinberg equilibrium (𝑃 > 0.05).
The frequencies of HLA-DRB1∗04 genotype were 6.75%
in control group, and 11.72% in TB group. HLA-DRB1∗04
genotype had a significant increased risk of TB (OR = 1.889;
𝑃 = 0.011). The frequency of HLA-DQB1∗0201 genotype
was 16.9% in control group and 25.6% in TB group. HLA-
DRB1∗0201 genotype had a significant increased risk of TB
(OR = 1.802; 𝑃 = 0.002) (Table 5).
4. Discussion
The association of host genetic factors with susceptibility
or resistance to TB has been studied extensively using
various methods, such as case-control studies, candidate
gene approaches and family-based, and genome-wide linkage
analyses that have revealed several important candidate genes
for susceptibility [12–14].
Solute carrier family 11A member 1 (SLC11A1), formerly
known as natural resistance-associated macrophage protein
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Table 5: The allele frequency distribution of HLA-DRB1 and HLA-DQB1 genes in the controls and TB patients of the Chinese Kazakh
population.
Alleles Tuberculosis𝑁 (Freq) Control𝑁 (Freq) 𝜒2 OR (95% CI) 𝑃
HLA-DRB1
01 19 (4.2) 17 (3.77) 0.111 1.123 (0.568–2.220) 0.739
03 12 (5.19) 7 (1.53) 1.350 1.746 (0.675–4.516) 0.245
04 51 (11.72) 30 (6.75) 6.495 1.889 (1.153–3.095) 0.011
07 30 (12.99) 24 (5.36) 0.726 1.281 (0.724–2.267) 0.394
08 17 (3.75) 14 (3.09) 0.297 1.226 (0.589–2.549) 0.585
09 7 (1.53) 12 (2.64) 1.395 0.568 (0.219–1.469) 0.238
10 13 (2.86) 5 (1.09) 3.664 2.683 (0.941–7.654) 0.056
11 3 (0.66) 8 (1.76) 2.351 0.365 (0.096–1.394) 0.125
12 19 (4.2) 13 (2.87) 1.181 1.496 (0.721–3.106) 0.277
13 15 (3.3) 12 (2.64) 0.340 1.262 (0.577–2.758) 0.560
14 16 (3.53) 10 (2.2) 1.440 1.637 (0.727–3.688) 0.230
15 42 (18.18) 31 (6.98) 1.913 1.427 (0.861–2.364) 0.617
16 8 (1.75) 6 (1.31) 0.286 1.339 (0.457–1.024) 0.593
HLA-DQB1
0201 103 (25.6) 71 (16.9) 9.231 1.802 (1.230–2.639) 0.002
0301/4 16 (3.5) 13 (2.87) 0.317 1.242 (0.583–2.645) 0.573
0302/3 13 (2.9) 7 (1.53) 1.885 1.900 (0.744–4.852) 0.173
0303 22 (4.88) 18 (3.99) 0.419 1.240 (0.646–2.379) 0.517
0304 19 (4.2) 14 (3.09) 0.793 1.383 (0.676–2.829) 0.373
0401 24 (5.34) 25 (5.59) 0.028 0.951 (0.526–1.719) 0.867
0402 26 (5.79) 32 (7.21) 0.740 0.785 (0.451–1.364) 0.390
0501 47 (10.75) 41 (9.1) 0.474 1.177 (0.739–1.875) 0.491
0502 39 (8.83) 53 (12.27) 2.738 0.678 (0.428–1.076) 0.120
0503 11 (2.41) 9 (1.97) 0.200 1.228 (0.499–3.021) 0.655
0504 17 (3.75) 20 (4.45) 0.279 0.834 (0.425–1.637) 0.597
0601 51 (12.14) 36 (8.16) 3.108 1.527 (0.952–2.449) 0.078
0602 29 (6.49) 38 (8.63) 1.461 0.725 (0.430–1.223) 0.227
0603/8 14 (3.08) 23 (5.13) 2.423 0.581 (0.291–1.159) 0.120
0604 31 (6.95) 25 (5.59) 0.702 1.271 (0.725–2.229) 0.402
Note:𝑁: the sample size; OR: odds ratio; 95%, CI: 95% confidence interval; Freq: frequency.
1 (NRAMP1), is a human homologue of the mouse Nramp1
gene, and a single nonconservative amino acid substitution in
this protein controls susceptibility to Leishmania, Salmonella,
and Mycobacteria in inbred mouse strains [15]. SLC11A1
activates microbicidal responses in the infected macrophage,
and it is, therefore, important in the early innate response
to mycobacterial infection. Its exact function is still unclear,
but the fact that it is known to find in the late endosome
fraction [16], and some of its homologues have been shown
to be divalent cation transporters, and has led to speculation
that Nramp1 may control intracellular microbial replication
by actively removing iron or other divalent cations from
the phagosomal space [17, 18]. While iron is an essential
mycobacterial nutrient, it is also required by the cell to
generate reactive oxygen and nitrogen intermediates. Diva-
lent cations are also essential cofactors for enzymes, such
as superoxide dismutase and catalase, which neutralize the
cytotoxic effects of the oxidative burst in macrophages [19].
NRAMP1 polymorphic variants have been associated with
susceptibility to TB and leprosy as well as autoimmune
diseases [20, 21].
3󸀠UTR has a 4 bp TGTG deletion located 55 nt down-
streamof the last codon in exon 15. In theChineseKazak pop-
ulation, the frequency of 3󸀠UTR TGTG+/del genotype was
significantly higher in the patient group than in the control
group, indicating that the TGTG+/del genotype frequency is
associated with an increased risk of TB. There was a signifi-
cant difference betweenTBpatients andhealthy controls.Our
date also showed that the frequency of 3󸀠UTR TGTGdel/del
genotype was three times as high in the patient group than in
the control group, indicating that the TGTGdel/del genotype
frequency is associated with an increased risk of TB. There
was significant difference between TB patients and healthy
controls.
Four NRAMP1 polymorphisms (3󸀠UTR, INT4, D543N,
and 5󸀠(GT)n) were found to be significantly associated with
tuberculosis in West Africans [22]. In Koreans [23, 24] and
Chinese Han [25], a significant association with TB was
detected for 3󸀠UTR polymorphism. However, in Cambodi-
ans, the 3󸀠UTR variants were associated with resistance to
TB [26]. In Taiwanese [27],Thai [28], Moroccans [29], Danes
[30], and Brazilian [31], there were no associations between
the 3󸀠UTR variants and TB. In the present study, we found
that the 3󸀠UTR polymorphisms have a relatively high risk for
TB in the Chinese Kazak population (OR = 1.859; 95% CI =
1.182–2.926; 𝑃 = 0.002). The results presented here show that
in the Chinese Kazak population there were associations of
the 3󸀠UTR variants with susceptibility to TB.
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Vitamin D metabolism can lead to the activation of
macrophages and subsequently restrict the intracellular
growth of M. TB [32, 33].This effect is achieved by binding to
VDR in the monocytes, and the polymorphism in the VDR
gene is suggested to be involved in genetic susceptibility to
TB.
In theChineseKazak population, the frequencies of FokI-
Ff and ff genotypes were higher in the patient group than
in the control group, indicating that the Ff and ff genotype
frequencies are associated with an increased risk of TB.There
was a significant difference between TB patients and healthy
controls. No significant differences of TaqI-Tt and tt genotype
frequencies were observed between TB patients and healthy
controls.
The relation between VDR gene polymorphism and
susceptibility to TB has been studied in different populations.
Polymorphisms of the VDR gene have been associated with
TB resistance inThe Gambia, and data showed a significantly
lower frequency of TaqI-tt genotype among TB patients [34].
Among Gujarati Asians in West London [35], a significant
interaction between vitamin D status and FokI and TaqI
genotypes was also observed. In Tuvinians fromTuva Repub-
lic and Russians from Tomsk City, no association between
FokI genotype and PTBwas found [36]. A study in Cambodia
[26] and Tanzania [37] found no association between VDR
gene and PTB. In Chinese Han population [25], FokI-ff is
associated with susceptibility to PTB, but there is no any
significant association between the disease and TaqI. In this
study, we found that the FokI polymorphisms have a relatively
high risk for TB in theChineseKazak population (OR= 1.530;
95% CI = 1.007–2.325; 𝑃 = 0.001). The FokI polymorphisms
were associatedwith TB in theChineseKazak population, but
there is no any significant association between the disease and
TaqI.
The aim of the present study is to report that the
polymorphisms of theNRAMP1 gene (3󸀠UTR) andVDRgene
(FokI) are significantly associated with TB and may be a
risk factor for the development of TB in the Chinese Kazak
population. But TaqI is not associated with the TB patients
and healthy controls.
The human leucocyte antigen (HLA) system plays an
important role in the modulation of the immune response.
Epidemiological and experimental studies suggest that the
high degree of molecular diversity in HLA molecules influ-
ences the variability in the human response to TB. An
association between HLA and TB has been examined in
several populations, but the results have been inconsistent.
The HLA class II variant, DR2 encoded by alleles DRB1∗15
and DRB1∗16, is associated with TB in several populations
[38, 39], but not in others [40, 41]. In South Africans
[42], a significant interaction betweenHLA-DRB1∗1302 allele
and susceptibility to TB was observed. A study in Poland
[43, 44] showed that there was an interaction between HLA-
DQB1∗05 allele and susceptibility to TB and a significant
interaction between HLA-DRB1∗16 and HLA-DRB1∗14 allele
and susceptibility to TB was also observed. In Koreans [45],
a significant interaction between HLA-DQB1∗0601 allele
and susceptibility to TB was observed. In Mexcians [46],
a significant interaction between HLA-DQ genotype and
susceptibility to TB was also observed. The less common
DQB1∗0503 HLA class II allele associated with TB in Cam-
bodia [41] was shown. In this study, the HLA-DRB1∗04 and
HLA-DQB1∗0201 alleles were associated with TB (OR = 1.889
and 1.802; 95% CI = 1.153–3.095 and 1.230–2.639; 𝑃 = 0.011
and 0.002, resp.); the results were different from other ethnic
groups.
Gene polymorphisms are influenced by different ethnic,
geographical, and other factors. Differences in genetic back-
ground among different races have also led to the genotype
frequency distribution that appeared quite different. Sample
size, case and control groups of sources, inclusion criteria,
and different technical factors may also lead to different
results. Further studies are required on the function of these
genes. Further analyses are necessary to clearly elucidate
the mechanisms by which the gene might affect disease
progression. The findings of this study provide data for the
assessment of risk profiles regarding susceptibility to TB. We
anticipate that the determination of ethnic-specific genetic
associations with TB susceptibilitymay guide TB therapy and
prophylaxis in an ethnic-specific manner.
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